B R Davis

Data monitoring in clinical trials: the case for stochastic curtailment.

B R Davis, R J Hardy, B. Davis, 1994, Journal of clinical epidemiology.

Survival analysis of adverse effects data in the Beta‐Blocker Heart Attack Trial

B R Davis, B. Davis, C. Furberg, 1987, Clinical pharmacology and therapeutics.

Coronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly Program.

B R Davis, B. Davis, J. Stamler, 1996, Circulation.

Prevalence of Postural Hypotension at Baseline in the Systolic Hypertension in the Elderly Program (SHEP) Cohort

B R Davis, B. Davis, W. Applegate, 1991, Journal of the American Geriatrics Society.

Differences in precision of dietary estimates among different population subgroups.

B R Davis, M D Blaufox, M. Blaufox, 1993, Annals of epidemiology.

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

B R Davis, B. Davis, P. Whelton, 1996, American journal of hypertension.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

E. J. Brown, L A Moyé, B R Davis, 1992, The New England journal of medicine.

Isolated systolic hypertension : prognostic information provided by pulse pressure.

B R Davis, B. Davis, M. Pfeffer, 1999, Hypertension.